stephen tukwasibwe - Infectious Diseases

Author Information

Stephen Tukwasibwe is affiliated with the Infectious Diseases Research Collaboration in Kampala, Uganda. His work primarily focuses on infectious diseases, with a significant emphasis on malaria research. Through his studies, he explores genetic variations, drug resistance, and immune responses related to malaria, particularly in Ugandan populations.

Research Contributions

Stephen Tukwasibwe has made substantial contributions to the understanding of malaria, particularly in relation to genetic factors and drug resistance. His research delves into the diversity of KIR genes and their HLA-C ligands, as well as the evolution of drug resistance in Plasmodium falciparum. His work has provided insights into the genetic underpinnings of malaria resistance and susceptibility, helping to inform strategies for dealing with malaria transmission and resistance in Africa.

Aliases

Stephen Tukwasibwe is also known by the alias Steven Tukwasibwe. This variation of his name may appear in certain publications or records.

Publication and Citation Metrics

Metric	Value
Citation Count	558
H-index	13
Paper Count	29

Publications:

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity

DOI: 10.21203/rs.3.rs-45487/v2

Year: 2021

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity

DOI: 10.1186/s12936-021-03652-y

Year: 2021

A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa

DOI: 10.1016/j.ijpddr.2021.06.001

Year: 2021

Balanced impacts of fitness and drug pressure on the evolution of PfMDR1 polymorphisms in Plasmodium falciparum

DOI: 10.1186/s12936-021-03823-x

Year: 2021

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity

DOI: 10.21203/rs.3.rs-45487/v1

Year: 2020

Associations between Aminoquinoline Resistance Genotypes and Clinical Presentations of Plasmodium falciparum Infection in Uganda

DOI: 10.1128/AAC.00721-20

Year: 2020

Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria

DOI: 10.1038/s41423-020-0482-z

Year: 2020

Ugandan schoolchildren selects for Plasmodium falciparum transporter

DOI:

Year: 2018

Associations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control study

DOI: 10.1371/journal.pone.0203229

Year: 2018

Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda

DOI: 10.1186/s12936-017-1777-0

Year: 2017

How are Antimalarial Drugs Used?

How Are Drug Targets Identified?

What is the National Institutes of Health (NIH)?

What is the Global Impact of Rabies?

What is the Treatment for Measles?

What Could Be Causing Weight Loss?

What are Infectious Agents?

What is the Emergency Use Authorization (EUA)?

What is an Infectious Disease Surveillance System?

Is There a Vaccine for Yellow Fever?

Partnered Content Networks

Relevant Topics